CRBP - Corbus Pharmaceuticals Holdings, Inc.

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts1122
Avg. Estimate-3.1-3.1-44.1-52.7
Low estimate-3.1-3.1-74.7-95.1
High estimate-3.1-3.1-13.5-10.3
Year ago EPS-3.3-2.1-10.15-44.1
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts1111
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history29/06/202229/09/202230/12/202230/03/2023
Est. EPS-1.8-1.65-2.1-4.09
Actual EPS-3.3-2.1-2.61-4.24
Difference-1.5-0.45-0.51-0.15
Surprise %-83.30%-27.30%-24.30%-3.70%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate-3.1-3.1-44.1-52.7
7 days ago-3.1-3.1-44.1-52.7
30 days ago-2.35-2.39-42.96-53.22
60 days ago-2.35-2.39-42.96-53.22
90 days ago-2.35-2.39-41.7-38.18
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/A1
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesCRBPIndustrySector(s)S&P 500
Current qtr.6.10%N/AN/AN/A
Next qtr.-47.60%N/AN/AN/A
Current year-334.50%N/AN/AN/A
Next year-19.50%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A